Cognitive-Behavior Therapy Versus Pharmacotherapy: Now That the Jury's Returned Its Verdict, It's Time to Present the Rest of the Evidence

Recent reanalyses suggest that pharmacotherapy was superior to cognitive-behavior therapy in the acute treatment of more severely depressed outpatients in the National Institute of Mental Health Treatment of Depression Collaborative Research Program (TDCRP). At the same time, this finding was neithe...

Full description

Saved in:
Bibliographic Details
Published in:Journal of consulting and clinical psychology 1996-02, Vol.64 (1), p.74-80
Main Authors: Jacobson, Neil S, Hollon, Steven D
Format: Article
Language:English
Subjects:
Adults
Antidepressive Agents, Tricyclic - therapeutic use
Behavior Modification
Behavior therapy. Cognitive therapy
Biological and medical sciences
Cognitive Behavior Therapy
Cognitive Behavioral Therapy
Cognitive behaviour therapy
Cognitive Restructuring
Cognitive Therapy
Comparison
Counseling
Depression
Depression (Psychology)
Depressive Disorder - drug therapy
Depressive Disorder - psychology
Drug Therapy
Drugs
Emotional Disturbances
Experimental Methods
Human
Humans
Imipramine - therapeutic use
Intervention
Major Depression
Medical sciences
Mental depression
National Institute of Mental Health
Outpatient Care
Panic Disorder
Panic Disorder - psychology
Panic Disorder - therapy
Personality Problems
Pharmacology
Pharmacotherapy
Placebo
Psychology
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Psychotropic Drugs - therapeutic use
Therapy
Treatment
Treatment Effectiveness Evaluation
Treatment Outcome
Treatments
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Recent reanalyses suggest that pharmacotherapy was superior to cognitive-behavior therapy in the acute treatment of more severely depressed outpatients in the National Institute of Mental Health Treatment of Depression Collaborative Research Program (TDCRP). At the same time, this finding was neither robust across sites within the TDCRP nor consistent with findings from other studies. D. F. Klein has argued that those other studies were inherently flawed because they did not include pill-placebo controls, an argument that he extended to drug-psychotherapy comparisons in the treatment of panic as well. It is agreed that the inclusion of such controls would have facilitated the interpretation of the findings, but it is not agreed that their omission rendered those studies uninterpretable. Cognitive-behavior therapy remains a viable alternative to pharmacotherapy in the treatment of depression and a particularly promising intervention in the treatment of panic disorder.
ISSN:0022-006X
1939-2117
DOI:10.1037/0022-006X.64.1.74